Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Digital Therapeutics Topic Center

FDA approval stamp
News
FDA Approves First Prescription Digital Therapeutic for Adjunctive Major Depressive Disorder Treatment
04/30/2024
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as...
04/30/2024
Psych Congress Network
Brain Training Aids Overall Cognitive Ability in Adults With ADHD
News
Brain Training Aids Overall Cognitive Ability in Adults With ADHD
10/02/2023
Computerized cognitive training interventions may offer a small benefit for overall cognitive outcomes in adults with attention-deficit/hyperactivity disorder (ADHD), according to a systematic review and meta-analysis published in...
Computerized cognitive training interventions may offer a small benefit for overall cognitive outcomes in adults with attention-deficit/hyperactivity disorder (ADHD), according to a systematic review and meta-analysis published in...
Computerized cognitive training...
10/02/2023
Psych Congress Network
digital brain
News
Digital Therapeutic Eases Experiential Negative Symptoms in Patients with Schizophrenia
09/09/2023
A beta version of a prescription digital therapeutic significantly reduced experiential negative symptoms in patients with schizophrenia, according to a poster presentation at Psych Congress.
A beta version of a prescription digital therapeutic significantly reduced experiential negative symptoms in patients with schizophrenia, according to a poster presentation at Psych Congress.
A beta version of a prescription...
09/09/2023
Psych Congress Network
talking with psychiatrist
News
Wrist-wearable Device Biomarkers May Help Predict Adverse Posttraumatic Neuropsychiatric Symptoms
01/23/2023
Wrist-wearable device biomarkers may be useful screening tools for pain, sleep, and anxiety symptom treatment outcomes after trauma exposure.
Wrist-wearable device biomarkers may be useful screening tools for pain, sleep, and anxiety symptom treatment outcomes after trauma exposure.
Wrist-wearable device biomarkers...
01/23/2023
Psych Congress Network
News
Virtual Reality-Based Treatment Shows No Effect on Social Cognition in Patients With Schizophrenia
01/10/2023
The test program, DiSCoVR, indicated current SCT protocols are “unsuitable.”
The test program, DiSCoVR, indicated current SCT protocols are “unsuitable.”
The test program, DiSCoVR,...
01/10/2023
Psych Congress Network
News
Prenatal Depression Screening, Referral Improves After Online Provider Training
01/02/2023
Screening for prenatal depression and referral for care increased after providers underwent a brief online training intervention, study says.
Screening for prenatal depression and referral for care increased after providers underwent a brief online training intervention, study says.
Screening for prenatal...
01/02/2023
Psych Congress Network
News
Online Pain Programs Reduce Anxiety, Depressive Symptoms in People With Chronic Pain
12/26/2022
An online pain management program reduced anxiety and depressive symptoms in adults with chronic pain, according to study results published online ahead of print in Pain Medicine.
An online pain management program reduced anxiety and depressive symptoms in adults with chronic pain, according to study results published online ahead of print in Pain Medicine.
An online pain management...
12/26/2022
Psych Congress Network
Dr Steven Chan at Psych Congress Elevate
Videos
Telehealth Chatbots Promising, but Need Further Research
11/08/2022
Steven Chan, MD, MBA, talks research that supports or challenges mental health apps in clinical practice.
Steven Chan, MD, MBA, talks research that supports or challenges mental health apps in clinical practice.
Steven Chan, MD, MBA, talks...
11/08/2022
Psych Congress Network
News
FDA Clears Neuromodulation System for Patients With MDD
09/19/2022
The US Food and Drug Administration has provided Magnus Medical Inc. 510(k) clearance for the SAINT Neuromodulation System for the treatment of MDD in adults who have not achieved adequate improvement from prior antidepressant medications in...
The US Food and Drug Administration has provided Magnus Medical Inc. 510(k) clearance for the SAINT Neuromodulation System for the treatment of MDD in adults who have not achieved adequate improvement from prior antidepressant medications in...
The US Food and Drug...
09/19/2022
Psych Congress Network
News
At-Home Transcranial Direct Current Stimulation Helps Attention in Adults with ADHD
08/09/2022
Four weeks of daily, home-based transcranial direct current stimulation (tDCS) improved attention in adults with ADHD not taking stimulant medication, according to a small sham-controlled trial.
Four weeks of daily, home-based transcranial direct current stimulation (tDCS) improved attention in adults with ADHD not taking stimulant medication, according to a small sham-controlled trial.
Four weeks of daily, home-based...
08/09/2022
Psych Congress Network
Dr Steven Chan
Videos
Assess Features and Set Realistic Expectations When Choosing and Using Apps in Clinical Practice
08/08/2022
Steven Chan, MD, MBA, discusses the expectations clinicians should set when utilizing apps in their clinical practice and how to integrate them with electronic health record (EHR) systems.
Steven Chan, MD, MBA, discusses the expectations clinicians should set when utilizing apps in their clinical practice and how to integrate them with electronic health record (EHR) systems.
Steven Chan, MD, MBA, discusses...
08/08/2022
Psych Congress Network

Advertisement

News

FDA approval stamp
News
FDA Approves First Prescription Digital Therapeutic for Adjunctive Major Depressive Disorder Treatment
04/30/2024
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as...
04/30/2024
Psych Congress Network
Brain Training Aids Overall Cognitive Ability in Adults With ADHD
News
Brain Training Aids Overall Cognitive Ability in Adults With ADHD
10/02/2023
Computerized cognitive training interventions may offer a small benefit for overall cognitive outcomes in adults with attention-deficit/hyperactivity disorder (ADHD), according to a systematic review and meta-analysis published in...
Computerized cognitive training interventions may offer a small benefit for overall cognitive outcomes in adults with attention-deficit/hyperactivity disorder (ADHD), according to a systematic review and meta-analysis published in...
Computerized cognitive training...
10/02/2023
Psych Congress Network
digital brain
News
Digital Therapeutic Eases Experiential Negative Symptoms in Patients with Schizophrenia
09/09/2023
A beta version of a prescription digital therapeutic significantly reduced experiential negative symptoms in patients with schizophrenia, according to a poster presentation at Psych Congress.
A beta version of a prescription digital therapeutic significantly reduced experiential negative symptoms in patients with schizophrenia, according to a poster presentation at Psych Congress.
A beta version of a prescription...
09/09/2023
Psych Congress Network
talking with psychiatrist
News
Wrist-wearable Device Biomarkers May Help Predict Adverse Posttraumatic Neuropsychiatric Symptoms
01/23/2023
Wrist-wearable device biomarkers may be useful screening tools for pain, sleep, and anxiety symptom treatment outcomes after trauma exposure.
Wrist-wearable device biomarkers may be useful screening tools for pain, sleep, and anxiety symptom treatment outcomes after trauma exposure.
Wrist-wearable device biomarkers...
01/23/2023
Psych Congress Network
News
Virtual Reality-Based Treatment Shows No Effect on Social Cognition in Patients With Schizophrenia
01/10/2023
The test program, DiSCoVR, indicated current SCT protocols are “unsuitable.”
The test program, DiSCoVR, indicated current SCT protocols are “unsuitable.”
The test program, DiSCoVR,...
01/10/2023
Psych Congress Network
News
Prenatal Depression Screening, Referral Improves After Online Provider Training
01/02/2023
Screening for prenatal depression and referral for care increased after providers underwent a brief online training intervention, study says.
Screening for prenatal depression and referral for care increased after providers underwent a brief online training intervention, study says.
Screening for prenatal...
01/02/2023
Psych Congress Network
News
Online Pain Programs Reduce Anxiety, Depressive Symptoms in People With Chronic Pain
12/26/2022
An online pain management program reduced anxiety and depressive symptoms in adults with chronic pain, according to study results published online ahead of print in Pain Medicine.
An online pain management program reduced anxiety and depressive symptoms in adults with chronic pain, according to study results published online ahead of print in Pain Medicine.
An online pain management...
12/26/2022
Psych Congress Network
News
FDA Clears Neuromodulation System for Patients With MDD
09/19/2022
The US Food and Drug Administration has provided Magnus Medical Inc. 510(k) clearance for the SAINT Neuromodulation System for the treatment of MDD in adults who have not achieved adequate improvement from prior antidepressant medications in...
The US Food and Drug Administration has provided Magnus Medical Inc. 510(k) clearance for the SAINT Neuromodulation System for the treatment of MDD in adults who have not achieved adequate improvement from prior antidepressant medications in...
The US Food and Drug...
09/19/2022
Psych Congress Network
News
At-Home Transcranial Direct Current Stimulation Helps Attention in Adults with ADHD
08/09/2022
Four weeks of daily, home-based transcranial direct current stimulation (tDCS) improved attention in adults with ADHD not taking stimulant medication, according to a small sham-controlled trial.
Four weeks of daily, home-based transcranial direct current stimulation (tDCS) improved attention in adults with ADHD not taking stimulant medication, according to a small sham-controlled trial.
Four weeks of daily, home-based...
08/09/2022
Psych Congress Network
News
FDA Grants Breakthrough Device Designation to Investigate Deep Brain Stimulation System in TRD
08/04/2022
The FDA recently granted Abbott a breakthrough device designation to investigate the use of its deep brain stimulation system for patients with treatment-resistant depression, a form of major depressive disorder.
The FDA recently granted Abbott a breakthrough device designation to investigate the use of its deep brain stimulation system for patients with treatment-resistant depression, a form of major depressive disorder.
The FDA recently granted Abbott...
08/04/2022
Psych Congress Network
Three illustrated faces, one sad, one neutral, one happy, with a human hand picking up the happy face
News
Add-on Intravenous Racemic Ketamine May be Best for Treatment-Resistant Depression
11/19/2024
Augmentative treatment with intravenous racemic ketamine in adults with treatment-resistant unipolar depression appears to be better than augmentative intranasal esketamine or aripiprazole.
Augmentative treatment with intravenous racemic ketamine in adults with treatment-resistant unipolar depression appears to be better than augmentative intranasal esketamine or aripiprazole.
Augmentative treatment with...
11/19/2024
Psych Congress Network
Acute Care Utilization Lower When Buprenorphine Doses Are Higher
News
Acute Care Utilization Lower When Buprenorphine Doses Are Higher
11/19/2024
US adults with OUD who received buprenorphine at doses higher than recommended by the FDA had lower rates of urgent health care utilization than those whose doses were in line with FDA recommendations.
US adults with OUD who received buprenorphine at doses higher than recommended by the FDA had lower rates of urgent health care utilization than those whose doses were in line with FDA recommendations.
US adults with OUD who received...
11/19/2024
Psych Congress Network
neurology brain stress
News
Targeted Lucidity Reactivation May Help Ease Narcolepsy-Related Nightmares
11/18/2024
Results from a pilot study of patients with narcolepsy provide proof-of-concept evidence that a procedure called targeted lucidity reactivation can be adapted for narcolepsy-related nightmares.
Results from a pilot study of patients with narcolepsy provide proof-of-concept evidence that a procedure called targeted lucidity reactivation can be adapted for narcolepsy-related nightmares.
Results from a pilot study of...
11/18/2024
Neurology
Treatment Discontinuation Rates Lower With Methadone Than Buprenorphine/Naloxone
News
Treatment Discontinuation Rates Lower With Methadone Than Buprenorphine/Naloxone
11/18/2024
Methadone was associated with a lower risk of treatment discontinuation than buprenorphine/naloxone among patients with opioid use disorder, according to study findings published in JAMA.
Methadone was associated with a lower risk of treatment discontinuation than buprenorphine/naloxone among patients with opioid use disorder, according to study findings published in JAMA.
Methadone was associated with a...
11/18/2024
Psych Congress Network
A doctor examines a patient who has a head injury from soccer
News
Concussion With Depression Worsens Symptoms, Brain Connectivity
11/15/2024
The comorbidity of depression and sports-related concussion amplifies symptoms of both conditions, according to study findings published in Brain Research.
The comorbidity of depression and sports-related concussion amplifies symptoms of both conditions, according to study findings published in Brain Research.
The comorbidity of depression...
11/15/2024
Psych Congress Network
Adults Who Smoke Have More Chronic Pain, Use More Opioids
News
Adults Who Smoke Have More Chronic Pain, Use More Opioids
11/15/2024
Rates of chronic pain, prescription opioid use, and severe work limitations rise with the number of cigarettes smoked daily, according to study results published in the American Journal of Preventive Medicine.
Rates of chronic pain, prescription opioid use, and severe work limitations rise with the number of cigarettes smoked daily, according to study results published in the American Journal of Preventive Medicine.
Rates of chronic pain,...
11/15/2024
Psych Congress Network
a caregiver speaks with a doctor
News
Caregivers Confirm Usability of Schizophrenia Cognition Rating Scale
11/14/2024
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving...
11/14/2024
Psych Congress Network
Patient survey
News
Patient Survey Identifies Barriers to TD Treatment
11/06/2024
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive...
11/06/2024
Psych Congress Network
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
depression stock photo
News
Add-on Lumateperone Eases MDD in Patients With Inadequate Antidepressant Response
11/04/2024
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Adjunctive treatment with the...
11/04/2024
Psych Congress Network

Insights

Dr Steven Chan at Psych Congress Elevate
Videos
Telehealth Chatbots Promising, but Need Further Research
11/08/2022
Steven Chan, MD, MBA, talks research that supports or challenges mental health apps in clinical practice.
Steven Chan, MD, MBA, talks research that supports or challenges mental health apps in clinical practice.
Steven Chan, MD, MBA, talks...
11/08/2022
Psych Congress Network
Dr Steven Chan
Videos
Assess Features and Set Realistic Expectations When Choosing and Using Apps in Clinical Practice
08/08/2022
Steven Chan, MD, MBA, discusses the expectations clinicians should set when utilizing apps in their clinical practice and how to integrate them with electronic health record (EHR) systems.
Steven Chan, MD, MBA, discusses the expectations clinicians should set when utilizing apps in their clinical practice and how to integrate them with electronic health record (EHR) systems.
Steven Chan, MD, MBA, discusses...
08/08/2022
Psych Congress Network
Steven Chan
Videos
How to Evaluate and Integrate Apps Into Treatment With Dr Steven Chan
07/26/2022
Steven Chan, MD, MBA, discusses the ways apps can be integrated into treatment plans and summarizes key elements of the APA's app evaluation model.
Steven Chan, MD, MBA, discusses the ways apps can be integrated into treatment plans and summarizes key elements of the APA's app evaluation model.
Steven Chan, MD, MBA, discusses...
07/26/2022
Psych Congress Network
Jonathan Meyer, MD
Videos
Unpacking Negative Symptoms, Medication Adverse Effects, and Emerging Schizophrenia Treatments
11/11/2024
Jonathan Meyer, MD, offers his clinical insights on schizophrenia management.
Jonathan Meyer, MD, offers his clinical insights on schizophrenia management.
Jonathan Meyer, MD, offers his...
11/11/2024
Psych Congress Network
Desiree Matthews
Schizophrenia Conference Insights
New Class of Medication Offers Innovative Treatment for Schizophrenia Symptoms
11/07/2024
Watch these exclusive insights with Desiree Matthews, PMHNP-BC, to learn how this novel treatment could reshape the landscape of care for adults living with schizophrenia.
Watch these exclusive insights with Desiree Matthews, PMHNP-BC, to learn how this novel treatment could reshape the landscape of care for adults living with schizophrenia.
Watch these exclusive insights...
11/07/2024
Psych Congress Network
Marc Agronin
Videos
Implementing Alzheimer Disease Prevention Practices
11/02/2024
Dr Marc Agronin discusses some easy prevention strategies for Alzheimer disease following his Psych Congress 2024 session "A New Era for Alzheimer’s Disease: Prevention, Early Diagnosis, Effective Intervention."
Dr Marc Agronin discusses some easy prevention strategies for Alzheimer disease following his Psych Congress 2024 session "A New Era for Alzheimer’s Disease: Prevention, Early Diagnosis, Effective Intervention."
Dr Marc Agronin discusses some...
11/02/2024
Psych Congress Network
Christoph Correll, MD.
Videos
Strategies to Manage Adverse Effects From Schizophrenia Treatment
10/28/2024
Christoph Correll, MD, offers clinical guidance for managing adverse affects from schizophrenia treatment, including weight gain and movement disorder
Christoph Correll, MD, offers clinical guidance for managing adverse affects from schizophrenia treatment, including weight gain and movement disorder
Christoph Correll, MD, offers...
10/28/2024
Psych Congress Network
Christoph Correll, MD
Videos
Beyond D2 Receptor Manipulation: Novel Agents for Schizophrenia Treatment
10/16/2024
Christoph Correll, MD, provides a thorough pharmacological overview of the traditional and novel treatments available for schizophrenia.
Christoph Correll, MD, provides a thorough pharmacological overview of the traditional and novel treatments available for schizophrenia.
Christoph Correll, MD, provides...
10/16/2024
Psych Congress Network
Christoph Correll, MD
Videos
Recognizing the Early Indicators of Schizophrenia
10/08/2024
Christoph Correll, MD, reviews some of the key prodromal and accentuated psychotic symptoms that serve as early indicators of schizophrenia.
Christoph Correll, MD, reviews some of the key prodromal and accentuated psychotic symptoms that serve as early indicators of schizophrenia.
Christoph Correll, MD, reviews...
10/08/2024
Psych Congress Network
Desiree Matthews, PMHNP-BC, CEO
Videos
Best Practices for Prescribing Long-Acting Injectable Medications Via Telehealth
09/30/2024
Desiree Matthews, PMHNP-BC, CEO, Different MHP, highlights how providers can integrate medication management into their virtual practices—especially for patients needing long-acting injectable (LAI) antipsychotics.
Desiree Matthews, PMHNP-BC, CEO, Different MHP, highlights how providers can integrate medication management into their virtual practices—especially for patients needing long-acting injectable (LAI) antipsychotics.
Desiree Matthews, PMHNP-BC, CEO,...
09/30/2024
Psych Congress Network
Timothy Wilens, MD
Videos
Managing Life Transitions in ADHD: Why Early Preparation is Critical
09/18/2024
Timothy Wilens, MD, provides practical clinical guidance for supporting patients with ADHD through life transitions.
Timothy Wilens, MD, provides practical clinical guidance for supporting patients with ADHD through life transitions.
Timothy Wilens, MD, provides...
09/18/2024
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement